Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Claus

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
Plos Genetics|April 18, 2013
Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kBAngela Garding, Nupur Bhattacharya, Rainer Claus, et al.
Neuro-Oncology|April 19, 2013
Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collectiveBenedikt Wiestler, Rainer Claus, Sabine A Hartlieb, et al.
Cancer Discovery|August 30, 2012
Genome-wide DNA methylation events in TMPRSS2-ERG fusion-negative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylationStefan T Börno, Axel Fischer, Martin Kerick, et al.
Pediatric Blood & Cancer|March 16, 2026
European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and AdolescentsMichaela Kuhlen, Calogero Virgone, Antje Redlich, et al.
Leukemia & Lymphoma|February 28, 2015
Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997David M Lucas, Amy S Ruppert, Gerard Lozanski, et al.
Blood|May 27, 2026
Mutant IDH1 blocks neutropoiesis by repressing myeloid progenitor programsMariam Hakobyan, Jens Langstein, María José Ramos Medina, et al.
Blood|May 29, 2014
Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemiaRainer Claus, David M Lucas, Amy S Ruppert, et al.
Oncotarget|November 24, 2016
Prognostic relevance of miRNA-155 methylation in anaplastic gliomaMaximilian Georg Schliesser, Rainer Claus, Thomas Hielscher, et al.
The New England Journal of Medicine|January 22, 2025
Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal CancerJens Hoeppner, Thomas Brunner, Claudia Schmoor, et al.
JCO Precision Oncology|September 11, 2020
Personalized Clinical Decision Making Through Implementation of a Molecular Tumor Board: A German Single-Center ExperienceRouven Hoefflin, Anna-Lena Geißler, Ralph Fritsch, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
Plos Genetics|April 18, 2013
Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kBAngela Garding, Nupur Bhattacharya, Rainer Claus, et al.
Neuro-Oncology|April 19, 2013
Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collectiveBenedikt Wiestler, Rainer Claus, Sabine A Hartlieb, et al.
Cancer Discovery|August 30, 2012
Genome-wide DNA methylation events in TMPRSS2-ERG fusion-negative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylationStefan T Börno, Axel Fischer, Martin Kerick, et al.
Pediatric Blood & Cancer|March 16, 2026
European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and AdolescentsMichaela Kuhlen, Calogero Virgone, Antje Redlich, et al.
Leukemia & Lymphoma|February 28, 2015
Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997David M Lucas, Amy S Ruppert, Gerard Lozanski, et al.
Blood|May 27, 2026
Mutant IDH1 blocks neutropoiesis by repressing myeloid progenitor programsMariam Hakobyan, Jens Langstein, María José Ramos Medina, et al.
Blood|May 29, 2014
Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemiaRainer Claus, David M Lucas, Amy S Ruppert, et al.
Oncotarget|November 24, 2016
Prognostic relevance of miRNA-155 methylation in anaplastic gliomaMaximilian Georg Schliesser, Rainer Claus, Thomas Hielscher, et al.
The New England Journal of Medicine|January 22, 2025
Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal CancerJens Hoeppner, Thomas Brunner, Claudia Schmoor, et al.
JCO Precision Oncology|September 11, 2020
Personalized Clinical Decision Making Through Implementation of a Molecular Tumor Board: A German Single-Center ExperienceRouven Hoefflin, Anna-Lena Geißler, Ralph Fritsch, et al.
Pageof 13